FeesSafety
Pluang+

Zymeworks to present at two major healthcare investor conferences in Miami.

Market News
19 Nov 2026, 13:00 WIB
GlobeNewsWire
View Source
Neutral
Zymeworks to present at two major healthcare investor conferences in Miami.

Zymeworks Inc., a biotechnology company, announced it will participate in the Evercore Healthcare Conference on November 30 and Citi’s 2026 Global Healthcare Conference on December 1, both in Miami. The company's management will engage in one-on-one meetings and fireside chats, with some sessions webcast live and available for replay. This participation highlights Zymeworks' ongoing efforts to showcase its diversified biotherapeutics pipeline and licensed healthcare assets to investors. The events provide an opportunity to update stakeholders on the company's progress and strategic direction.

Zymeworks' participation in upcoming investor conferences provides context for readers following healthcare stocks. For readers following healthcare stocks, here is Pluang's market snapshot as of Nov 19, 2026 17:01 WIB: Of 150 priced US health-sector stocks tradable on Pluang, 83 rose and 58 fell today. Notable movers included AbCellera Biologics Inc (ABCL) with a 3.99% gain at USD 11.46 and Dyne Therapeutics Inc. (DYN) up 3.97% at USD 16.50, while Haleon plc (HLN) declined 3.96% to USD 8.72.

More News

Ferrari shows strong profits and brand exclusivity; Rivian grows fast but faces losses and risks.

Ferrari shows strong profits and brand exclusivity; Rivian grows fast but faces losses and risks.

Ferrari maintains high profitability by limiting production and preserving brand exclusivity, generating $8.2 billion revenue and $1.8 billion net income with a 22% margin in the past year. Rivian, focused on expanding electric vehicle production and...

Market News
Neutral
1 hour ago
Top 10 stock picks revealed with 794% average return vs. S&P 500's 203%.

Top 10 stock picks revealed with 794% average return vs. S&P 500's 203%.

Stock Advisor's analyst team has identified the 10 best stocks to buy right now, boasting an impressive total average return of 794%, far outperforming the S&P 500's 203% return. This insight offers investors a strong opportunity to potentially maxim...

Bullish
1 hour ago
Stock valuations are high by some metrics but not clear signals of a market drop.

Stock valuations are high by some metrics but not clear signals of a market drop.

The Shiller CAPE ratio and Buffett indicator show U.S. stocks are historically expensive, with CAPE at 40 and Buffett indicator near 250%, levels seen only during major past market peaks. However, other measures like the forward P/E ratio suggest mor...

Neutral
1 hour ago
Berkshire Hathaway's insurance profits dip in Q3 amid rising claims and lower interest rates.

Berkshire Hathaway's insurance profits dip in Q3 amid rising claims and lower interest rates.

Berkshire Hathaway's insurance segment, a major profit contributor, saw a decline in Q3 earnings due to increased claims, higher broker commissions, and more advertising costs at GEICO. Additionally, lower interest rates reduced investment income fro...

Company Fundamentals
Bearish
1 hour ago
Anthropic's $120B deal with SpaceX boosts merger talks with Tesla and AI infrastructure bets.

Anthropic's $120B deal with SpaceX boosts merger talks with Tesla and AI infrastructure bets.

Anthropic plans to spend up to $120.5 billion with SpaceX's AI-focused subsidiary through 2029, paying about $3.1 billion monthly starting December. This deal supports SpaceX's AI infrastructure investments and strengthens its financial position ahea...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App